Spok Holdings, Inc. (NASDAQ:SPOK – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 253,100 shares, a decline of 30.8% from the November 15th total of 366,000 shares. Based on an average daily volume of 106,900 shares, the days-to-cover ratio is presently 2.4 days.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. B. Riley assumed coverage on Spok in a research report on Thursday, September 26th. They issued a “neutral” rating and a $15.00 target price on the stock. StockNews.com upgraded Spok from a “hold” rating to a “buy” rating in a research report on Friday, October 25th.
Read Our Latest Stock Report on Spok
Hedge Funds Weigh In On Spok
Spok Trading Down 0.4 %
NASDAQ SPOK traded down $0.07 during trading on Friday, reaching $16.70. The company’s stock had a trading volume of 53,267 shares, compared to its average volume of 93,768. Spok has a 12 month low of $13.24 and a 12 month high of $18.14. The firm has a 50 day moving average price of $15.87 and a 200 day moving average price of $15.33. The firm has a market capitalization of $338.51 million, a price-to-earnings ratio of 22.88 and a beta of 0.33.
Spok Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, December 9th. Shareholders of record on Monday, November 18th were paid a dividend of $0.313 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.25 dividend on an annualized basis and a yield of 7.50%. Spok’s dividend payout ratio (DPR) is presently 171.23%.
Spok Company Profile
Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.
Further Reading
- Five stocks we like better than Spok
- Are Penny Stocks a Good Fit for Your Portfolio?
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Compound Interest and Why It Matters When Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Insider Buying Explained: What Investors Need to Know
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Spok Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spok and related companies with MarketBeat.com's FREE daily email newsletter.